Showing results (291-300 of 310) with videos related to

Sort By:
Pageof 31
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2006
Targeted deletion of CCR2 impairs deep vein thombosis resolution in a mouse modelPeter K Henke, Charles G Pearce, Daria M Moaveni, et al.
ALTEX|October 22, 2024
Impact of gut permeability on estimation of oral bioavailability for chemicals in commerce and the environmentGregory S Honda, Elaina M Kenyon, Sarah Davidson-Fritz, et al.
Thrombosis and Haemostasis|February 24, 2006
Neutrophils modulate post-thrombotic vein wall remodeling but not thrombus neovascularizationPeter K Henke, Manu R Varma, K Barry Deatrick, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 19, 2019
Assessing Toxicokinetic Uncertainty and Variability in Risk PrioritizationJohn F Wambaugh, Barbara A Wetmore, Caroline L Ring, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 14, 2018
A somatic activating NRAS variant associated with kaposiform lymphangiomatosisSarah F Barclay, Kyle W Inman, Valerie L Luks, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 1, 2018
Evaluating In Vitro-In Vivo Extrapolation of ToxicokineticsJohn F Wambaugh, Michael F Hughes, Caroline L Ring, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|January 1, 2019
Evaluation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) mutagenicity using in vitro and in vivo Pig-a assaysRoberta A Mittelstaedt, Vasily N Dobrovolsky, Javier R Revollo, et al.
Plos One|April 16, 2025
Enabling transparent toxicokinetic modeling for public health risk assessmentSarah E Davidson-Fritz, Caroline L Ring, Marina V Evans, et al.
Environmental and Molecular Mutagenesis|December 15, 2011
Report on stage III Pig-a mutation assays using N-ethyl-N-nitrosourea-comparison with other in vivo genotoxicity endpointsZoryana Cammerer, Javed A Bhalli, Xuefei Cao, et al.
Pageof 31